4//SEC Filing
Marques Tiago 4
Accession 0001213900-24-019219
CIK 0001841330other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 9:46 PM ET
Size
8.5 KB
Accession
0001213900-24-019219
Insider Transaction Report
Form 4
Marques Tiago
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-01+15,000→ 15,000 totalExercise: $8.34Exp: 2034-02-28→ Common Stock (15,000 underlying) - Award
Stock Option (right to buy)
2024-03-01+11,669→ 11,669 totalExercise: $8.34Exp: 2034-02-28→ Common Stock (11,669 underlying)
Footnotes (2)
- [F1]The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains a director or otherwise in continuous service to the Issuer through such vesting date.
- [F2]The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001875240
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 9:46 PM ET
- Size
- 8.5 KB